The rapid 10 percent growth of sterile drug product over the past 5 years is being aided by the rise in biologics, orphan drugs, oncology, therapeutics, as well as other environmental factors. As a result, Thermo Fisher Scientific understands the critical need for robust and flexible early development solutions, so you can:
Scaling to commercial manufacturing can be arduous as you try to balance speed, regulatory and the supply chain. Thermo Fisher Scientific offers experience, reliability, and a broad range of sterile fill/finish commercial solutions that enable you to:
From development to launch, pharma products navigate a dynamic global supply chain with potential changes and delays. To manage these changes, pharmaceutical companies go to great lengths to understand the status of production, mitigate risk, and proactively forecast. With integrated data sources, smart analytics, and a collaboration-first approach, mysupply Platform drives attention to where it matters most.
Already using the mysupply Platform? Login here.
Download our Sterile Dose Form brochure.
